Patient's question:
The baby is three and a half months old. Six days after birth, due to jaundice, the baby was admitted to the neonatal department for one week, with indirect bilirubin as the main issue, while other bacteria, viruses, endocrine, and hemolysis were negative. After treatment, the baby recovered and was discharged. Upon discharge, the sclera was still yellow, and later the skin turned yellow again. When the baby was two months old, the jaundice became (obvious), and the baby was admitted again. Cytomegalovirus was positive, with urine cytomegalovirus DNA at 4800, and no abnormalities were found in other genetic metabolism. After two weeks of ganciclovir antiviral and altorphanol liver protection treatment, a follow-up liver function test showed ALT 113 and AST 92. The baby was discharged and continued oral Tianqing (galactosamine) and ursodeoxycholic acid for liver protection treatment. Twenty days later, a follow-up test showed urine cytomegalovirus DNA at 523, ALT at 140, and AST at 91. Is a second course of antiviral treatment necessary? Are there better oral liver protection medications?Doctor's answer:
The infant currently does not have any antiviral drugs for hepatitis B and should only receive liver protection and enzyme-lowering treatment. However, it is also necessary to understand the amount of virus. Generally, antiviral treatment is not recommended for those under 6 years old, and oral antiviral drugs are not used for those under 12 years old. Interferon can be administered when necessary. It is recommended to complete the HBV-DNA test. Liver protection and immune enhancement treatment can be provided.